{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:14:31Z","timestamp":1763003671150,"version":"3.45.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["8 P20 GM103527"],"award-info":[{"award-number":["8 P20 GM103527"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022750","name":"Office of the Vice President for Research, University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023736","name":"Office of the Vice President for Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007472","name":"University of Kentucky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007472","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016479","name":"Jazz Pharmaceuticals Inc Ewing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015087","name":"Markey Cancer Center, University of Kentucky","doi-asserted-by":"publisher","award":["P30CA177558"],"award-info":[{"award-number":["P30CA177558"]}],"id":[{"id":"10.13039\/100015087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jtct.2023.07.023","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T19:04:17Z","timestamp":1690571057000},"page":"608.e1-608.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Role of Defibrotide in the Prevention of Murine Model Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.1016","volume":"29","author":[{"given":"Senthilnathan","family":"Palaniyandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reena","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6905-0813","authenticated-orcid":false,"given":"Ethan","family":"Strattan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Kohler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nashwan","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Kesler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0478-3340","authenticated-orcid":false,"given":"Gerhard C.","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.07.023_bib0001","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0268-960X(03)00009-2","article-title":"Immunobiology of acute graft-versus-host disease","volume":"17","author":"Reddy","year":"2003","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2023.07.023_bib0002","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2023.07.023_bib0003","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.beha.2008.02.002","article-title":"Vascular endothelium as 'novel' target of graft-versus-host disease","volume":"21","author":"Tichelli","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jtct.2023.07.023_bib0004","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","article-title":"CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation","volume":"9","author":"Edinger","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jtct.2023.07.023_bib0005","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1182\/blood-2015-10-676924","article-title":"Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure","volume":"127","author":"Richardson","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.07.023_bib0006","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/bloodadvances.2017008375","article-title":"The use of defibrotide in blood and marrow transplantation","volume":"2","author":"Richardson","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.07.023_bib0007","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2023.07.023_bib0008","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/1078-0432.CCR-08-1270","article-title":"Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasias","volume":"15","author":"Mitsiades","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtct.2023.07.023_bib0009","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4161\/cbt.6.5.3959","article-title":"Defibrotide: an endothelium protecting and stabilizing drug, has an anti-angiogenic potential in vitro and in vivo","volume":"6","author":"Koehl","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jtct.2023.07.023_bib0010","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s40261-014-0242-x","article-title":"Defibrotide: a review of its use in severe hepatic veno-occlusive disease following haematopoietic stem cell transplantation","volume":"34","author":"Keating","year":"2014","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jtct.2023.07.023_bib0011","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bmt.1704930","article-title":"Oligotide, a defibrotide derivative, protects human microvascular endothelial cells against fludarabine-induced activation, damage and allogenicity","volume":"35","author":"Eissner","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.07.023_bib0012","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/bmt.2017.121","article-title":"Endothelial damage is aggravated in acute GvHD and could predict its development","volume":"52","author":"Mir","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.07.023_bib0013","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1172\/JCI119612","article-title":"The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide","volume":"100","author":"Panoskaltsis-Mortari","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2023.07.023_bib0014","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood.V88.8.3230.bloodjournal8883230","article-title":"An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.07.023_bib0015","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.4049\/jimmunol.173.9.5467","article-title":"Target antigens determine graft-versus-host disease phenotype","volume":"173","author":"Kaplan","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2023.07.023_bib0016","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI3132","article-title":"Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation","volume":"102","author":"Hill","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2023.07.023_bib0017","doi-asserted-by":"crossref","first-page":"e00401","DOI":"10.1128\/JVI.00401-19","article-title":"In vivo live imaging of oncolytic mammalian orthoreovirus expressing NanoLuc luciferase in tumor xenograft mice","volume":"93","author":"Kanai","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.jtct.2023.07.023_bib0018","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1182\/blood-2012-05-429506","article-title":"Selective inhibitors of nuclear export show that CRM1\/XPO1 is a target in chronic lymphocytic leukemia","volume":"120","author":"Lapalombella","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.07.023_bib0019","doi-asserted-by":"crossref","first-page":"7026","DOI":"10.4049\/jimmunol.1001293","article-title":"Neutrophil migration across intestinal epithelium: evidence for a role of CD44 in regulating detachment of migrating cells from the luminal surface","volume":"185","author":"Brazil","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2023.07.023_bib0020","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1083\/jcb.150.6.1479","article-title":"Sustained polymorphonuclear leukocyte transmigration induces apoptosis in T84 intestinal epithelial cells","volume":"150","author":"Le'Negrate","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jtct.2023.07.023_bib0021","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1182\/blood-2017-10-812891","article-title":"Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onset","volume":"131","author":"H\u00fclsd\u00fcnker","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.07.023_bib0022","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nm.3517","article-title":"Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage","volume":"20","author":"Schwab","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jtct.2023.07.023_bib0023","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fimmu.2020.00489","article-title":"Diagnosis and treatment of VOD\/SOS after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Bonifazi","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2023.07.023_bib0024","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fimmu.2017.00079","article-title":"Pathophysiology of GvHD and other HSCT-related major complications","volume":"8","author":"Ghimire","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2023.07.023_bib0025","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood.V95.9.2754.009k25_2754_2759","article-title":"The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation","volume":"95","author":"Hill","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.07.023_bib0026","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.4049\/jimmunol.1500117","article-title":"Cytokines in graft-versus-host disease","volume":"194","author":"Henden","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2023.07.023_bib0027","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1182\/blood.2021011216","article-title":"Increased efficacy of dual proinflammatory cytokine blockade on acute GVHD while maintaining GVT effects","volume":"138","author":"Khuat","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.07.023_bib0028","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/labinvest.3700541","article-title":"CD95 ligand-dependent endothelial cell death initiates oral mucosa damage in a murine model of acute graft versus host disease","volume":"87","author":"Deschaumes","year":"2007","journal-title":"Lab Invest"},{"key":"10.1016\/j.jtct.2023.07.023_bib0029","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.bbmt.2014.04.030","article-title":"Predictive value of circulating angiopoietin-2 for endothelial damage-related complications in allogeneic hematopoietic stem cell transplantation","volume":"20","author":"Ueda","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.07.023_bib0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1734-1140(09)70004-0","article-title":"ICAM-1 signaling in endothelial cells","volume":"61","author":"Lawson","year":"2009","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.jtct.2023.07.023_bib0031","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00007890-199303000-00022","article-title":"The immunopathology of upper gastrointestinal acute graft-versus-host disease. Lymphoid cells and endothelial adhesion molecules","volume":"55","author":"Roy","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2023.07.023_bib0032","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/10245330400001975","article-title":"Cytokine profiles in stem cell transplantation: possible use as a predictor of graft-versus-host disease","volume":"10","author":"Lunn","year":"2005","journal-title":"Hematology"},{"key":"10.1016\/j.jtct.2023.07.023_bib0033","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1053\/j.gastro.2008.08.053","article-title":"CD44 deficiency attenuates chronic murine ileitis","volume":"135","author":"Collins","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtct.2023.07.023_bib0034","first-page":"399","article-title":"Defibrotide in vitro inhibits neutrophil activation by a Ca++-involving mechanism","volume":"9","author":"Di Perri","year":"1987","journal-title":"Int J Tissue React"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723014355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723014355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:11:33Z","timestamp":1763003493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723014355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2666636723014355"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.07.023","relation":{},"ISSN":["2666-6367"],"issn-type":[{"type":"print","value":"2666-6367"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Defibrotide in the Prevention of Murine Model Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}